| Product Code: ETC7555783 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
India continues to see a steady rise in import shipments of transdermal scopolamine patches, with top exporting countries in 2024 including Germany, Singapore, Sri Lanka, Spain, and even India itself. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI) in 2024. The compound annual growth rate (CAGR) for the period 2020-2024 stands at 3.95%, showing consistent growth. Moreover, the growth rate from 2023 to 2024 has accelerated to 4.29%, highlighting the increasing demand for this medical product in India.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Transdermal Scopolamine Patch Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F |
3.3 India Transdermal Scopolamine Patch Market - Industry Life Cycle |
3.4 India Transdermal Scopolamine Patch Market - Porter's Five Forces |
3.5 India Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Transdermal Scopolamine Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of motion sickness in India |
4.2.2 Growing awareness about the benefits of transdermal scopolamine patches |
4.2.3 Rising demand for non-invasive drug delivery systems in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in India |
4.3.2 Limited availability of skilled healthcare professionals for prescribing transdermal scopolamine patches |
5 India Transdermal Scopolamine Patch Market Trends |
6 India Transdermal Scopolamine Patch Market, By Types |
6.1 India Transdermal Scopolamine Patch Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 India Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F |
6.2 India Transdermal Scopolamine Patch Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F |
6.2.3 India Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F |
6.2.4 India Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F |
6.2.5 India Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F |
7 India Transdermal Scopolamine Patch Market Import-Export Trade Statistics |
7.1 India Transdermal Scopolamine Patch Market Export to Major Countries |
7.2 India Transdermal Scopolamine Patch Market Imports from Major Countries |
8 India Transdermal Scopolamine Patch Market Key Performance Indicators |
8.1 Number of prescriptions for transdermal scopolamine patches |
8.2 Patient adherence rate to using transdermal scopolamine patches |
8.3 Rate of adverse events reported related to transdermal scopolamine patch usage |
8.4 Number of clinical trials and research studies conducted on transdermal scopolamine patches in India |
8.5 Adoption rate of transdermal scopolamine patches compared to traditional oral medications |
9 India Transdermal Scopolamine Patch Market - Opportunity Assessment |
9.1 India Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Transdermal Scopolamine Patch Market - Competitive Landscape |
10.1 India Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024 |
10.2 India Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |